The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The endogenous cannabinoid system controls extinction of aversive memories
Abstract
Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their binding to central nervous system receptors (e.g.CB1 receptors), endocannabinoids have been shown, e.g., to reduce anxiety (Marsicano et al., 2002;Lutz et al., 2015) and increase food intake (Di Marzo et al., 2001).”
From Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (2016) · cites this paper as Marsicano et al., 2002
In the citing paper
“Moreover, there is an emerging body of evidence demonstrating an important role for CB1 receptor-mediated endocannabinoid signaling in the extinction of aversive memories8.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [8]
In the citing paper
“As part of this protective role under aversive conditions, elevated EC signaling during stress has been shown to dampen the development of anxiety [12] and to regulate the encoding [13], retrieval [14] and extinction [15] of traumatic memories.”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [15]
In the citing paper
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“Marsicano and colleagues reported elevated AEA and 2-AG BLA levels after extinction training in mice [86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“and produced impairments in extinction learning (but not fear conditioning) by CB1R KO or systemic antagonist (SR141716A) administration [28,86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“The cannabinoid system is part of the complex circuitry that regulates anxiety and stress and is a crucial mediator of emotional learning (Marsicano et al, 2002;Viveros et al, 2005;Patel et al, 2005Patel et al, , 2005a; Laviolette and Grace, 2006;Varvel et al, 2007;Ganon-Elazar and Akirav, 2009;Lutz, 2009;Hill et al, 2009;Abush and Akirav, 2010;Akirav, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Marsicano et al, 2002
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
The role of ventromedial prefrontal cortex in the recovery of extinguished fear
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06225.2000 · Cited by 957 · cited 1×
“; however, there is increasing evidence that some cellular pathways are specifically involved in extinction, but not in acquisition or consolidation of fear memorie”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationExtinction of emotional learning: contribution of medial prefrontal cortex
Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90241-c · Cited by 897 · cited 1×
“To confirm this assumption, we measured in C57BL/6J mice levels of the two major endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), in brain punches of the medial prefrontal cortex (mPFC) and the basolateral amygdala complex (BLAC), both of which are thought to have central roles in extinction of av…”
BackgroundOhno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Flagged first, then by citations
Research works printed but not linked: 1
- Franklin, K. B. J. & Paxinos, G. The Mouse Brain (Academic, San Diego, 1997)
Cited by
Sorted by citations
Items 701–800 of 1,005
Lin, Q., Yang, Q., Liu, D., Sun, Z., Dang, H., Liang, J., Wang, Y., Chen, J., & Li, S. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.07.011 · Cited by 51
von Rüden, E., Jafari, M., Bogdanović, R. M., Wotjak, C. T., & Potschka, H. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.001 · Cited by 51
Self-citationModulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1
Kiritoshi, T., Sun, H., Ren, W., Stauffer, S. R., Lindsley, C. W., Conn, P. J., & Neugebauer, V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.024 · Cited by 50
Deadwyler, S. A., Goonawardena, A. V., & Hampson, R. E. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2adb · Cited by 51
Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1
Kow, R. L., Jiang, K., Naydenov, A. V., Le, J. H., Stella, N., & Nathanson, N. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095922 · Cited by 51
Desroches, J., Charron, S., Bouchard, J., & Beaulieu, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.006 · Cited by 51
BDNF-TrkB signalling in fear learning: from genetics to neural networks
Musumeci, G., & Minichiello, L. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.031 · Cited by 51
Kodirov, S. A., Jasiewicz, J., Amirmahani, P., Psyrakis, D., Bonni, K., Wehrmeister, M., & Lutz, B. (2009) · Learning & Memory · doi:10.1101/lm.1663410 · Cited by 51
Self-citationEndogenous cannabinoid signaling at inhibitory interneurons
Younts, T. J., & Castillo, P. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.006 · Cited by 52
Bisogno, T., Burston, J. J., Rai, R., Allarà, M., Saha, B., Mahadevan, A., Razdan, R. K., Wiley, J. L., & Marzo, V. D. (2009) · ChemMedChem · doi:10.1002/cmdc.200800442 · Cited by 50
Self-citationChegini, H., Nasehi, M., & Zarrindast, M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.12.007 · Cited by 52
Gaffal, E., Cron, M., Glodde, N., Bald, T., Kuner, R., Zimmer, A., Lutz, B., & Tüting, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201777 · Cited by 50
Self-citationHohmann, U., & Dehghani, F. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0015 · Cited by 50
Salinas-Hernández, X. I., & Duvarci, S. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.635879 · Cited by 56
Functional consequences of the repeated administration of Δ9-tetrahydrocannabinol in the rat
Whitlow, C. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00135-2 · Cited by 50
Ohno‐Shosaku, T., Hashimotodani, Y., Maejima, T., & Kano, M. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.014 · Cited by 50
Manwell, L. A., Satvat, E., Lang, S. T., Allen, C. P., Leri, F., & Parker, L. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.002 · Cited by 48
Kwee, C., Baas, J. M. P., van der Flier, F. E., Groenink, L., Duits, P., Eikelenboom, M., van der Veen, D. C., Moerbeek, M., Batelaan, N. M., van Balkom, A. J. L. M., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.04.003 · Cited by 50
Hill, M. N., Barr, A. M., Ho, W. ‐. V., Carrier, E. J., Gorzalka, B. B., & Hillard, C. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04688.x · Cited by 49
Ratano, P., Everitt, B. J., & Milton, A. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.103 · Cited by 53
Saturnino, C., Petrosino, S., Ligresti, A., Palladino, C., Martino, G., Bisogno, T., & Marzo, V. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.134 · Cited by 49
Self-citationPerra, S., Pillolla, G., Luchicchi, A., & Pistis, M. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00588.x · Cited by 49
Endocannabinoid‐dependent plasticity at spinal nociceptor synapses
Kato, A., Punnakkal, P., Pernía‐Andrade, A. J., von Schoultz, C., Sharopov, S., Nyilas, R., Katona, I., & Zeilhofer, H. U. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.234229 · Cited by 50
Role of endocannabinoid system in mental diseases
Manzanares, J., Urigüen, L., Rubio, G., & Palomo, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033223 · Cited by 49
Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
Arguello, P. A., & Jentsch, J. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1953-0 · Cited by 49
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
Grant, I., & Cahn, B. R. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.015 · Cited by 51
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride, E. (2004) · PubMed · Cited by 49
Stopponi, S., Fotio, Y., Domi, A., Borruto, A. M., Natividad, L., Roberto, M., Ciccocioppo, R., & Cannella, N. (2018) · Addiction Biology · doi:10.1111/adb.12573 · Cited by 48
Crombie, K. M., Sartin‐Tarm, A., Sellnow, K. A., Ahrenholtz, R., Lee, S., Matalamaki, M., Adams, T. G., & Cisler, J. M. (2021) · Behaviour Research and Therapy · doi:10.1016/j.brat.2021.103867 · Cited by 48
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Bernal‐Chico, A., Tepavčević, V., Manterola, A., Utrilla, C. L., Matute, C., & Mato, S. (2022) · Glia · doi:10.1002/glia.24172 · Cited by 50
Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons
Requie, L. M., Gómez‐Gonzalo, M., Speggiorin, M., Managò, F., Melone, M., Congiu, M., Chiavegato, A., Lia, A., Zonta, M., Losi, G., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01193-4 · Cited by 50
Self-citationCluny, N. L., Chambers, A. P., Vemuri, K. V., Wood, J. T., Eller, L. K., Freni, C., Reimer, R. A., Makriyannis, A., & Sharkey, K. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.10.013 · Cited by 48
Horne, E. A., Coy, J. W., Swinney, K., Fung, S., Cherry, A. E., Marrs, W., Naydenov, A. V., Lin, Y. H., Sun, X., Keene, C. D., et al. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12045 · Cited by 49
Gentile, A., Fresegna, D., Musella, A., Sepman, H., Bullitta, S., Vito, F. D., Fantozzi, R., Usiello, A., Maccarrone, M., Mercuri, N. B., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0682-8 · Cited by 50
Self-citationOn the Involvement of BDNF Signaling in Memory Reconsolidation
González, M. C., Radiske, A., & Cammarota, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00383 · Cited by 50
Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
Fletcher-Jones, A., Hildick, K. L., Evans, A. J., Nakamura, Y., Henley, J. M., & Wilkinson, K. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00108 · Cited by 54
Combination of Rimonabant and Donepezil Prolongs Spatial Memory Duration
Wise, L. E., Iredale, P. A., Stokes, R. J., & Lichtman, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301297 · Cited by 48
Endocannabinoid regulation of relapse mechanisms
Fattore, L., Fadda, P., & Fratta, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.004 · Cited by 49
Chronic cannabinoid administration in vivo compromises extinction of fear memoryPreprint
Lin, H., Mao, S.-C., Chen, P. S., & Gean, P. (2008) · Learning & Memory · doi:10.1101/lm.1081908 · Cited by 52
Understanding the dynamic and destiny of memories
Alvares, L. D. O., & Monte, F. H. D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.03.009 · Cited by 51
Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation
Duncan, M., Galic, M. A., Wang, A., Chambers, A. P., McCafferty, D., McKay, D. M., Sharkey, K. A., & Pittman, Q. J. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00104.2013 · Cited by 47
Endocannabinoid system: Potential novel targets for treatment of schizophrenia
Saito, A., Ballinger, M. D., Pletnikov, M. V., Wong, D. F., & Kamiya, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.020 · Cited by 47
Memory extinction entails the inhibition of the transcription factor NF-κB
Merlo, E., & Romano, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003687 · Cited by 47
Varvel, S. A., Cravatt, B. F., Engram, A. E., & Lichtman, A. H. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095059 · Cited by 47
Cannabinoids as therapeutics for PTSD
Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 47
Kimura, R., Silva, A. J., & Ohno, M. (2008) · Learning & Memory · doi:10.1101/lm.1049608 · Cited by 44
The 5-HT3A receptor is essential for fear extinctionPreprint
Kondo, M., Nakamura, Y., Ishida, Y., Yamada, T., & Shimada, S. (2013) · Learning & Memory · doi:10.1101/lm.032193.113 · Cited by 47
Pharmacological activation of kainate receptors drives endocannabinoid mobilization
Lourenço, J., Matias, I., Marsicano, G., & Mulle, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3512-10.2011 · Cited by 46
Self-citationGutiérrez‐Rodríguez, A., Puente, N., Elezgarai, I., Ruehle, S., Lutz, B., Reguero, L., Gerrikagoitia, I., Marsicano, G., & Grandes, P. (2017) · Journal of Comparative Neurology · doi:10.1002/cne.24066 · Cited by 46
Self-citationExtinction, renewal, and spontaneous recovery of a spatial preference in the water maze.
Lattal, K. M., Mullen, M. T., & Abel, T. G. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.5.1017 · Cited by 46
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors
Yamada, D., Takeo, J., Koppensteiner, P., Wada, K., & Sekiguchi, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.32 · Cited by 46
Rabinak, C. A., & Phan, K. L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990437 · Cited by 49
Campolongo, P., Ratano, P., Manduca, A., Scattoni, M. L., Palmery, M., Trezza, V., & Cuomo, V. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00011 · Cited by 52
Sophocleous, A., Marino, S., Kabir, D., Ralston, S. H., & Idris, A. I. (2017) · Aging Cell · doi:10.1111/acel.12638 · Cited by 45
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Sloan, M. E., Grant, C. W., Gowin, J. L., Ramchandani, V. A., & Foll, B. L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0081-z · Cited by 47
Nazario, L. R., Antonioli, R., Capiotti, K. M., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., Bonan, C. D., & da Silva, R. S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.008 · Cited by 50
Yuece, B., Sibaev, A., Broedl, U. C., Marsicano, G., Göke, B., Lutz, B., Allescher, H. D., & Storr, M. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00975.x · Cited by 46
Self-citationGenes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype
Aso, E., Ozaita, A., Serra, M.-À., & Maldonado, R. J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.007 · Cited by 46
Food for thought: endocannabinoid modulation of lipogenesis
Lichtman, A. H., & Cravatt, B. F. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25076 · Cited by 46
Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasksPreprint
Harloe, J. P., Thorpe, A. J., & Lichtman, A. H. (2008) · Learning & Memory · doi:10.1101/lm.1113008 · Cited by 47
Bouskila, J., Burke, M., Zabouri, N., Casanova, C., Ptito, M., & Bouchard, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.041 · Cited by 45
Marco, E. M., Rapino, C., Caprioli, A., Borsini, F., Maccarrone, M., & Laviola, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.044 · Cited by 49
Pharmacological Findings on the Biochemical Bases of Memory Processes: A General View
Izquierdo, I., Cammarota, M., Medina, J. H., & Bevilaqua, L. R. (2004) · Neural Plasticity · doi:10.1155/np.2004.159 · Cited by 45
Sink, K. S., Segovia, K. N., Collins, L. E., Markus, E. J., Vemuri, K. V., Makriyannis, A., & Salamone, J. D. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.011 · Cited by 44
Seillier, A., Aguilar, D. D., & Giuffrida, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.022 · Cited by 45
Wang, W., Yang, R., Hu, S., Wang, H., Ma, Z., & Yang, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.041 · Cited by 44
Chiodi, V., Uchigashima, M., Beggiato, S., Ferrante, A., Armida, M., Martire, A., Potenza, R. L., Ferraro, L., Tanganelli, S., Watanabe, M., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.017 · Cited by 45
Molecular Mechanisms of Threat Learning in the Lateral Nucleus of the Amygdala
Sears, R. M., Schiff, H. C., & LeDoux, J. E. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00010-6 · Cited by 44
Rueda‐Orozco, P. E., Montes-Rodríguez, C. J., Gómez, E. S., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.013 · Cited by 46
Bordicchia, M., Battistoni, I., Mancinelli, L., Giannini, E., Refi, G., Minardi, D., Muzzonigro, G., Roberta Mazzucchelli, A., Montironi, R., Piscitelli, F., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.018 · Cited by 45
Hermann, H., & Lutz, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.080 · Cited by 45
Self-citationInvolvement of the GABAergic system in PTSD and its therapeutic significance
Huang, J., Xu, F., Yang, L.-P., Tuolihong, L., Wang, X., Du, Z., Zhang, Y., Yin, X., Li, Y.-J. D., Lu, K., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1052288 · Cited by 41
Dubreucq, S., Kambiré, S. J., Conforzi, M., Metna‐Laurent, M., Cannich, A., Gómez, E. S., Richard, É. M., Marsicano, G., & Chaouloff, F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.049 · Cited by 44
Self-citationModulation of the extinction of fear learning
Myskiw, J. D. C., Izquierdo, I., & Furini, C. R. G. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.04.006 · Cited by 44
Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?
Kraft, B. (2012) · Pharmacology · doi:10.1159/000337376 · Cited by 45
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
Sudden amnesia resulting in pain relief: The relationship between memory and pain ☆
Choi, D. S., Choi, D. Y., Whittington, R. A., & Nedeljković, S. S. (2007) · Pain · doi:10.1016/j.pain.2007.06.025 · Cited by 44
Saito, V. M., Wotjak, C. T., & Moreira, F. A. (2010) · PubMed · Cited by 43
Self-citationExcitatory Amino Acid Neurotransmission
Zieglgänsberger, W., Parsons, C. G., & Danysz, W. (2005) · Springer eBooks · doi:10.1007/3-540-28082-0_10 · Cited by 47
Self-citationBessa, J. M., de Oliveira, M. A. R., Cerqueira, J., Almeida, O. F. X., & Sousa, N. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.005 · Cited by 44
Generating new neurons to circumvent your fears: the role of IGF signaling
Agís‐Balboa, R. C., & Fischer, A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1316-2 · Cited by 43
Lisboa, S. F. D. S., Borges, A. A., Nejo, P., Fassini, A., Guimarães, F. S., & Resstel, L. B. M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.005 · Cited by 44
Zer‐Aviv, T. M., Segev, A., & Akirav, I. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000253 · Cited by 43
Remmers, F., Lange, M. D., Hamann, M., Ruehle, S., Pape, H., & Lutz, B. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1411-5 · Cited by 44
Self-citationLocci, A., & Pinna, G. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.014 · Cited by 42
Colangeli, R., Morena, M., Pittman, Q. J., Hill, M. N., & Teskey, G. C. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0068-20.2020 · Cited by 44
Fyke, W., Premoli, M., Echeverry‐Alzate, V., López‐Moreno, J. A., Lemaire, V., Crusio, W. E., Marsicano, G., Wöhr, M., & Pietropaolo, S. (2021) · Autism Research · doi:10.1002/aur.2562 · Cited by 43
Self-citationFezza, F., Dillwith, J. W., Bisogno, T., Tucker, J. S., Marzo, V. D., & Sauer, J. R. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00087-8 · Cited by 43
Self-citationKaufmann, I., Hauer, D., Huge, V., Vogeser, M., Campolongo, P., Choukèr, A., Thiel, M., & Schelling, G. (2009) · European Surgical Research · doi:10.1159/000235870 · Cited by 43
Endocannabinoids: Getting the message across
Alger, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402935101 · Cited by 42
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases
Alvarenga, I. C., Panickar, K. S., Hess, H., & McGrath, S. (2023) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-081122-070236 · Cited by 47
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models
Puighermanal, E., Luna‐Sánchez, M., Gella, A., van der Walt, G., Urpi, A., Royo, M., Tena‐Morraja, P., Appiah, I., de Donato, M. H., Ménardy, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51884-8 · Cited by 41
Self-citationVarodayan, F. P., Soni, N., Bajo, M., Luu, G., Madamba, S. G., Schweitzer, P., Parsons, L. H., & Roberto, M. (2015) · Addiction Biology · doi:10.1111/adb.12256 · Cited by 42
Omiya, Y., Uchigashima, M., Konno, K., Yamasaki, M., Miyazaki, T., Yoshida, T., Kusumi, I., & Watanabe, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4681-14.2015 · Cited by 42
Ney, L. J., Matthews, A. J., Hsu, C. K., Zuj, D. V., Nicholson, E., Steward, T., Nichols, D. S., Graham, B. M., Harrison, B. J., Bruno, R., et al. (2021) · Depression and Anxiety · doi:10.1002/da.23170 · Cited by 43
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory
Ballinger, M. D., Saito, A., Abazyan, B. N., Taniguchi, Y., Huang, C.-H., Ito, K., Zhu, X., Segal‐Gavish, H., Jaaro-Peled, H., Sawa, A., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.006 · Cited by 42
Akirav, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301050 · Cited by 41
Gobira, P. H., Lima, I. V. D. A., Batista, L. A., de Oliveira, A. C., Resstel, L. B. M., Wotjak, C. T., de Aguiar, D. C., & Moreira, F. A. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691567 · Cited by 45
Self-citationCrombie, K. M., Adams, T. G., Dunsmoor, J. E., Greenwood, B. N., Smits, J. A. J., Nemeroff, C. B., & Cisler, J. M. (2023) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2023.102680 · Cited by 42
Tan, J., Duan, T., Zhou, Q., Ding, Z., Jing, L., Cao, J., Wang, L., Mao, R., & Xu, L. (2014) · Addiction Biology · doi:10.1111/adb.12158 · Cited by 41
Metadata
- Authors
- Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- LMU Klinikum (DE)
- Istituto di Chimica Biomolecolare (IT)
- Helmholtz Munich (DE)
- Corresponding author
- Lutz, Beat
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6897
- Pages
- 530-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982291289
- Cited by
- 1,728
- References
- 30
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 41 · 2023: 48 · 2022: 60 · 2021: 61 · 2020: 60 · 2019: 70 · 2018: 64 · 2017: 77 · 2016: 75 · 2015: 87 · 2014: 90 · 2013: 87 · 2012: 85
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, CB1 knockout mice, fear extinction, auditory fear conditioning, basolateral amygdala, long-term depression, GABAergic inhibition, SR141716A, memory consolidation, inhibitory neural networks
- MeSH terms
- Rimonabant, Acoustic Stimulation, Amygdala, Animals, Cannabinoids, Conditioning, Classical, Electrophysiology, Extinction, Psychological, Fear, gamma-Aminobutyric Acid, Male, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Synapses, Gene Deletion, Mice, Knockout, Receptors, Cannabinoid, Mice, Cannabinoid Receptor Modulators, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
